Stock 4587 PEPTIDREAM INC.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs PeptiDream Inc.

Equities

4587

JP3836750004

Biotechnology & Medical Research

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,622 JPY +1.66% Intraday chart for PeptiDream Inc. +10.45% +9.12%
Mar. 13 Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024. CI
Mar. 13 Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024. CI

ETFs positioned on PeptiDream Inc.

Name Weight AuM 1st Jan change Investor Rating
HAN-GINS INDXX HEALTHCARE MEGATREND EQUAL WEIGHT UCITS ETF - ACC - USD ETF HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF - Acc - USD
1.03% 16 M€ -8.49%
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY ETF Nomura NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY
0.54% 15 M€ +7.34%
DAIWA ETF FTSE BLOSSOM JAPAN INDEX ETF - JPY ETF Daiwa ETF FTSE Blossom Japan Index ETF - JPY
0.06% 14 M€ +15.63%
MAXIS JPX-NIKKEI 400 ETF - JPY ETF MAXIS JPX-Nikkei 400 ETF - JPY
0.04% 5,115 M€ +13.58%
NOMURA NEXT FUNDS JPX-NIKKEI INDEX 400 ETF - JPY ETF Nomura NEXT FUNDS JPX-Nikkei Index 400 ETF - JPY
0.04% 10,207 M€ +14.32%
NOMURA NEXT FUNDS MSCI JAPAN EMPOWERING WOMEN SELECT INDEX ETF - JPY ETF Nomura NEXT FUNDS MSCI Japan Empowering Women Select Index ETF - JPY
0.04% 60 M€ +14.42%
NZAM ETF TOPIX EX-FINANCIALS - JPY ETF NZAM ETF TOPIX Ex-Financials - JPY
0.03% 18 M€ +16.15% -
MAXIS TOPIX ETF - JPY ETF MAXIS TOPIX ETF - JPY
0.03% 20,721 M€ +13.52% -
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY ETF Nomura TOPIX Exchange Traded Fund ETF - JPY
0.03% 144,586 M€ +14.49%
DAIWA ETF TOPIX ETF - JPY ETF Daiwa ETF TOPIX ETF - JPY
0.03% 66,066 M€ +14.68% -
SPDR MSCI WORLD SMALL CAP UCITS ETF - USD ETF SPDR MSCI World Small Cap UCITS ETF - USD
0.01% 773 M€ -.--% -
DAIWA ETF MSCI JAPAN EMPOWERING WOMEN INDEX ETF - JPY ETF Daiwa ETF MSCI Japan Empowering Women Index ETF - JPY
0.01% 4 M€ +13.95%
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Developed Ex-US Plus Downside Convexity ETF - USD
0.01% 10 M€ -3.35% -
DEMOCRACY INTERNATIONAL FUND ETF - USD ETF Democracy International Fund ETF - USD
0.01% 7 M€ +1.95% -
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
0.00% 31 M€ +3.50% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.00% 389 M€ +6.83% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.00% 34 M€ +6.71% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.00% 39 M€ +3.67% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.00% 302 M€ +3.80% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +2.14% -

Company Profile

PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Sector
Biotechnology & Medical Research
Calendar
2024-05-13 - Q1 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for PeptiDream Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,622 JPY
Average target price
2,667 JPY
Spread / Average Target
+64.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PEPTIDREAM INC. Stock PeptiDream Inc.
+9.12% 1.34B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 4587 Stock
  4. Funds and ETFs PeptiDream Inc.